Literature DB >> 22665531

Early interim 2-(1)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical Hodgkin's lymphoma.

Alessandra Romano, Calogero Vetro, Daniela Donnarumma, Stefano Forte, Massimo Ippolito, Francesco Di Raimondo.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22665531      PMCID： PMC3366667          DOI： 10.3324/haematol.2012.064576

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma.

Authors:  Luis F Porrata; Kay Ristow; Joseph P Colgan; Thomas M Habermann; Thomas E Witzig; David J Inwards; Stephen M Ansell; Ivana N Micallef; Patrick B Johnston; Grzegorz S Nowakowski; Carrie Thompson; Svetomir N Markovic
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

Review 2.  The International Harmonization Project for response criteria in lymphoma clinical trials.

Authors:  Bruce D Cheson
Journal:  Hematol Oncol Clin North Am       Date:  2007-10       Impact factor: 3.722

3.  Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

Authors:  A Santoro; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.

Authors:  D Azambuja; Y Natkunam; I Biasoli; I S Lossos; M W Anderson; J C Morais; N Spector
Journal:  Ann Oncol       Date:  2011-05-20       Impact factor: 32.976

5.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Authors:  Christian Steidl; Tang Lee; Sohrab P Shah; Pedro Farinha; Guangming Han; Tarun Nayar; Allen Delaney; Steven J Jones; Javeed Iqbal; Dennis D Weisenburger; Martin A Bast; Andreas Rosenwald; Hans-Konrad Muller-Hermelink; Lisa M Rimsza; Elias Campo; Jan Delabie; Rita M Braziel; James R Cook; Ray R Tubbs; Elaine S Jaffe; Georg Lenz; Joseph M Connors; Louis M Staudt; Wing C Chan; Randy D Gascoyne
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

6.  Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Authors:  Andreas Engert; Volker Diehl; Jeremy Franklin; Andreas Lohri; Bernd Dörken; Wolf-Dieter Ludwig; Peter Koch; Mathias Hänel; Michael Pfreundschuh; Martin Wilhelm; Lorenz Trümper; Walter-Erich Aulitzky; Martin Bentz; Mathias Rummel; Orhan Sezer; Hans-Konrad Müller-Hermelink; Dirk Hasenclever; Markus Löffler
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

Review 7.  The disappearance of prognostic factors in Hodgkin's disease.

Authors:  D Hasenclever
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

8.  Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.

Authors:  Andrea Gallamini; Martin Hutchings; Luigi Rigacci; Lena Specht; Francesco Merli; Mads Hansen; Caterina Patti; Annika Loft; Francesco Di Raimondo; Francesco D'Amore; Alberto Biggi; Umberto Vitolo; Caterina Stelitano; Rosario Sancetta; Livio Trentin; Stefano Luminari; Emilio Iannitto; Simonetta Viviani; Ivana Pierri; Alessandro Levis
Journal:  J Clin Oncol       Date:  2007-07-23       Impact factor: 44.544

9.  A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Authors:  D Hasenclever; V Diehl
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.

Authors:  Jonathan A Harris; Salvia Jain; Qinghu Ren; Alirezah Zarineh; Cynthia Liu; Sherif Ibrahim
Journal:  Diagn Pathol       Date:  2012-01-30       Impact factor: 2.644
  10 in total
  8 in total

1.  Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.

Authors:  Theodoros P Vassilakopoulos; Maria N Dimopoulou; Maria K Angelopoulou; Kyriaki Petevi; Gerassimos A Pangalis; Maria Moschogiannis; Maria Dimou; George Boutsikas; Alexandros Kanellopoulos; Gabriella Gainaru; Eleni Plata; Pagona Flevari; Katerina Koutsi; Loula Papageorgiou; Vassilios Telonis; Panayiotis Tsaftaridis; Sotirios Sachanas; Xanthoula Yiakoumis; Pantelis Tsirkinidis; Nora-Athina Viniou; Marina P Siakantaris; Eleni Variami; Marie-Christine Kyrtsonis; John Meletis; Panayiotis Panayiotidis; Kostas Konstantopoulos
Journal:  Oncologist       Date:  2016-02-26

2.  Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma.

Authors:  Zsofia Simon; S Barna; Z Miltenyi; K Husi; F Magyari; A Jona; I Garai; Z Nagy; G Ujj; L Szerafin; A Illes
Journal:  Int J Hematol       Date:  2016-01       Impact factor: 2.490

Review 3.  Immunological deregulation in classic hodgkin lymphoma.

Authors:  Alessandra Romano; Calogero Vetro; Giovanni Caocci; Marianna Greco; Nunziatina Laura Parrinello; Francesco Di Raimondo; Giorgio La Nasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

4.  The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.

Authors:  Alessandra Romano; Nunziatina Laura Parrinello; Calogero Vetro; Daniele Tibullo; Cesarina Giallongo; Piera La Cava; Annalisa Chiarenza; Giovanna Motta; Anastasia L Caruso; Loredana Villari; Claudio Tripodo; Sebastiano Cosentino; Massimo Ippolito; Ugo Consoli; Andrea Gallamini; Stefano Pileri; Francesco Di Raimondo
Journal:  Oncotarget       Date:  2016-10-11

Review 5.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.

Authors:  Paulina Stefaniuk; Agnieszka Szymczyk; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

6.  Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.

Authors:  Vivek Naranbhai; Helen A Fletcher; Rachel Tanner; Matthew K O'Shea; Helen McShane; Benjamin P Fairfax; Julian C Knight; Adrian V S Hill
Journal:  EBioMedicine       Date:  2015-11       Impact factor: 8.143

7.  The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents.

Authors:  Alessandra Romano; Nunziatina Laura Parrinello; Claudio Cerchione; Maria Letizia Consoli; Marina Parisi; Valeria Calafiore; Enrica Martino; Concetta Conticello; Francesco Di Raimondo; Giuseppe Alberto Palumbo
Journal:  Blood Cancer J       Date:  2017-12-15       Impact factor: 11.037

8.  The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.

Authors:  Alessandra Romano; Chiara Pavoni; Francesco Di Raimondo; Corrado Tarella; Simonetta Viviani; Andrea Rossi; Caterina Patti; Marco Picardi; Maria Cantonetti; Giorgio La Nasa; Livio Trentin; Silvia Bolis; Valerio Zoli; Paolo Gavarotti; Paolo Corradini; Michele Cimminiello; Corrado Schiavotto; Guido Parvis; Roberta Zanotti; Guido Gini; Andrés J M Ferreri; Piera Viero; Stephane Chauvie; Alberto Biggi; Alessandro Massimo Gianni; Andrea Gallamini; Alessandro Rambaldi
Journal:  Cancer Med       Date:  2020-11-06       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.